SIGA - SIGA Technologies, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
About SIGA Technologies, Inc. (https://www.siga.com)
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Diem Nguyen | Chief Executive Officer & Director | 1972 | $1,390,500 USD |
| Daniel J. Luckshire | Executive Vice President, Chief Financial Officer & Secretary | 1971 | $1,316,441 USD |
| Dennis E. Hruby | Executive Vice President & Chief Scientific Officer | 1952 | $1,309,922 USD |
| Lawrence Miller | General Counsel & Corporate Secretary | 1968 | $1,042,875 USD |
| Herb Vloedman | Senior Vice President & Chief Information Officer | – | – |